Dermveda ULTRA BITE ITCH RELIEF

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Dermveda ULTRA BITE ITCH RELIEF
Generic name: MENTHA PIPERITA, CURCUMA LONGA
Manufacturer: Celcius Corp.
Product type: HUMAN OTC DRUG
SPL set ID: 232c344e-184d-4c95-bc2c-97c4c9cab091
SPL ID: f0ecbd75-2453-42c5-9ca7-03a3a6fabe65
Version: 2
Effective date: 2026-02-16
Source export date: 2026-09-28
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:19:01

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Dermveda ULTRA BITE ITCH RELIEF	openfda.brand_name
generic name		MENTHA PIPERITA, CURCUMA LONGA	openfda.generic_name
manufacturer name		Celcius Corp.	openfda.manufacturer_name
ndc	package	83819-106-02	openfda.package_ndc
ndc	product	83819-106	openfda.product_ndc
ndc11	package	83819010602	derived:openfda.package_ndc
spl id		f0ecbd75-2453-42c5-9ca7-03a3a6fabe65	id
spl set id		232c344e-184d-4c95-bc2c-97c4c9cab091	set_id
unii		79M2M2UDA9	openfda.unii
unii		856YO1Z64F	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. When using this product • Apply the product exclusively to affected areas. • Avoid application near or around the eyes. • Do not share this product with others to mitigate the risk of infection or viral transmission. Stop use and ask a doctor if • If symptoms persist or inflammation increases after weeks of use or if the itch increases. • Increase in redness on skin. Pregnant or Breast Feeding • Ask a Health Professional before use. Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.